Beforpharma at IV Italian Conference on Advanced Therapies

Beforpharma participated in the IV Italian Conference on Advanced Therapies and Radiopharmaceuticals, held in Rimini, Italy, from September 25 to 27, 2024.

The event brought together experts from Italy’s nuclear medicine industry and healthcare institutions. Numerous sessions focused on promising therapeutic strategies, including radioligand therapy associated with Lutetium-177-PSMA. Additionally, valuable information was provided regarding the regulatory management of radiopharmaceuticals.

The conference served as an excellent platform for Beforpharma to engage with leading Italian researchers and clinicians. The team was particularly interested in the sessions that explored the integration of advanced therapies into clinical practice.

In addition to attending the sessions, Beforpharma also participated in the discussions dedicated to the the challenges and opportunities in the development of radiopharmaceuticals.

The exchange of ideas and the collaborative spirit at the conference underscored the critical role of interdisciplinary efforts in pushing the boundaries of what’s possible in nuclear medicine and advanced therapies.